Importance of N-terminally truncated peptides in Alzheimer's disease

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [21] Generation of aggregation prone N-terminally truncated amyloid β peptides by meprin β depends on the sequence specificity at the cleavage site
    Schoenherr, Caroline
    Bien, Jessica
    Isbert, Simone
    Wichert, Rielana
    Prox, Johannes
    Altmeppen, Hermann
    Kumar, Sathish
    Walter, Jochen
    Lichtenthaler, Stefan F.
    Weggen, Sascha
    Glatzel, Markus
    Becker-Pauly, Christoph
    Pietrzik, Claus U.
    [J]. MOLECULAR NEURODEGENERATION, 2016, 11
  • [22] Assessment of N-terminally truncated parathyroid hormone in patients with hyperparathyroidism.
    Lu, CM
    Scheibel, S
    Cantor, T
    Cook, D
    Wolf, P
    Gao, P
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (02) : 284 - 285
  • [23] N-terminal truncated amyloid β-peptides and Alzheimer's disease -: Reply
    Russo, C
    Schettini, G
    Saido, TC
    Gambetti, P
    Tabaton, M
    Teller, JT
    [J]. NEUROBIOLOGY OF AGING, 2001, 22 (03) : 345 - 345
  • [24] Folding competence of N-terminally truncated forms of human procathepsin B
    Müntener, K
    Willimann, A
    Zwicky, R
    Svoboda, B
    Mach, L
    Baici, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) : 11973 - 11980
  • [25] Structure of an N-terminally truncated selenophosphate synthetase from Aquifex aeolicus
    Matsumoto, Eiko
    Sekine, Shun-ichi
    Akasaka, Ryogo
    Otta, Yumi
    Katsura, Kazushige
    Inoue, Mio
    Kaminishi, Tatsuya
    Terada, Takaho
    Shirouzu, Mikako
    Yokoyama, Shigeyuki
    [J]. ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2008, 64 : 453 - 458
  • [26] Identification of N-terminally arginylated proteins and peptides by mass spectrometry
    Xu, Tao
    Wong, Catherine C. L.
    Kashina, Anna
    Yates, John R., III
    [J]. NATURE PROTOCOLS, 2009, 4 (03) : 325 - 332
  • [27] Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated β-amyloid peptides
    Hoglund, K.
    Hansson, O.
    Buchhave, P.
    Zetterberg, H.
    Lewczuk, P.
    Londos, E.
    Blennow, K.
    Minthon, L.
    Wiltfang, J.
    [J]. NEURODEGENERATIVE DISEASES, 2008, 5 (05) : 268 - 276
  • [28] BREAKDOWN OF N-TERMINALLY MODIFIED PEPTIDES AND AN ISOPEPTIDE BY RUMEN MICROORGANISMS
    WALLACE, RJ
    FRUMHOLTZ, PP
    WALKER, ND
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1993, 59 (09) : 3147 - 3149
  • [29] Identification of N-terminally arginylated proteins and peptides by mass spectrometry
    Tao Xu
    Catherine C L Wong
    Anna Kashina
    John R Yates
    [J]. Nature Protocols, 2009, 4 : 325 - 332
  • [30] It All Starts at the Ends: Multifaceted Involvement of C- and N-Terminally Modified Cholinesterases in Alzheimer's Disease
    Berson, Amit
    Soreq, Hermona
    [J]. RAMBAM MAIMONIDES MEDICAL JOURNAL, 2010, 1 (02):
12345